The content on this site is intended for healthcare professionals only
Dr Pidhorecky speaks with ecancertv at Best of ASCO 2016 about improving patient outcomes in pancreatic cancer.
He describes how novel treatments are moving patients from non-resectionable disease towards operable tumours.
Dr Pidhorecky also introduces developments in lateral lymph node dissection for rectal cancer to more fully remove residual disease.
For more on combination capecitabine from Dr John Neoptolemos, click here.
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
